HomeNewsBusinessMarketsTrade Spotlight | How you should deal in Piramal Pharma, CDSL and FACT counters
Trending Topics

Trade Spotlight | How you should deal in Piramal Pharma, CDSL and FACT counters

FACT formed strong bullish candlestick pattern on the daily timeframe, with above average volumes. Also, the stock traded well above all key moving averages, which is a positive sign.

November 01, 2023 / 07:12 IST
Story continues below Advertisement
Stocks Views
Expert suggests strategy on Piramal Pharma, CDSL, FACT

After breaking a two-day winning streak with Bearish Belt Hold candlestick pattern on the daily charts on October 31, the trend seems to be favourable for bears who can drag the Nifty50 up to 19,000-18,900 zone amid consolidation in the coming sessions but major selling pressure looks unlikely, however, in case of an uptrend, 19,250-19,300 will be crucial for forming the base for an upward journey, experts said.

On October 31, the Nifty50 fell 61 points to 19,080, and the BSE Sensex was down 238 points at 63,875, while the advance decline ratio remained equal for yet another session. On the broader markets front, the Nifty Midcap 100 index gained 0.4 percent and Smallcap 100 index slipped 0.06 percent.

Story continues below Advertisement

Stocks that have seen buying interest despite correction in the market included Piramal Pharma, CDSL, and FACT. Piramal Pharma has seen breakout of long downward sloping resistance trendline adjoining highs of December 1, 2022 and September 7, 2023, and rallied 9.5 percent to Rs 104.5 on the NSE, forming long bullish candlestick pattern with upper shadow on the daily charts, with robust volumes.

CDSL also saw the breakout of a slightly downward sloping resistance trendline adjoining multiple touch points and formed healthy bullish candlestick pattern on the daily scale, with robust volumes. The stock jumped 6 percent to Rs 1,456 and traded well above all key moving averages (20, 50, 100 and 200-day EMA - exponential moving average), which is a positive sign.